adMare Academy Responds to Pandemic with New Pan-Canadian BioInnovation Scientist Program November 16, 2020: adMare BioInnovations, Canada’s global life sciences venture, is proud to announce the launch of its new…
Read More
The proceeds from the financing will fund Phase 1 & Phase 2 clinical trials of ZT-01, Zucara’s first-in-class drug candidate designed to prevent hypoglycemia in Type 1 Diabetes (T1D), a frequent, unintended consequence of insulin therapy for people with T1D & other types of insulin-dependent diabetes.
Vancouver and Montréal, Canada – October 15, 2020: adMare BioInnovations, Canada’s global life sciences venture, is pleased to announce the election of Mr. Didier Leconte, Vice President, Investments – Life Sciences…
If you are an academic researcher or a biotech company looking to pave the road to successful commercialization of your radiopharmaceutical innovation, join us on October 15th, 2020. What is CARI?…
New Pan-Canadian Partnership Looks to Commercialize the Country’s Most Promising Radiopharmaceutical Innovations September 17, 2020: The Centre for Probe Development and Commercialization (CPDC) and adMare BioInnovations (adMare) are pleased to…
adMare Academy Announces New Executive Institute Cohort Vancouver and Montreal, Canada – September 14, 2020: After receiving a record number of applications from across Canada, adMare BioInnovations (adMare) is pleased…
Inversago Pharma closes US$35M Series B financing round and expands Board of Directors Vancouver and Montreal, Canada – September 8, 2020: Inversago Pharma Inc. (“Inversago” or “the Company”), the peripheral…
Companies in CDL Health will benefit from adMare’s scientific and business expertise, infrastructure, and capital to drive health-related technologies to companies of scale. Vancouver and Montreal, Canada – July 16,…
New program supported by the Quebec Government and the City of Montreal looks to scale-up the province’s most promising young life sciences companies. Montreal, QC – June 29th, 2020: adMare…
June 26, 2020 – adMare BioInnovations, Canada’s global life sciences venture, is pleased to announce the appointment to its leadership team of Dr. Laura McIntosh as Venture Partner, Montreal, and…
